$81.22−$2.62 (-3.13%)as of market close, Aug 13, 2026
☾ After hours:$81.21+0.00%3:59 PM ET
BBIO monthly returns
BridgeBio Pharma Inc. has averaged 3.11% per month, positive in 53% of months. Month-by-month returns for BridgeBio Pharma Inc. (BBIO) below, through August 13, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+3.1%
80 months
Best month
+103.5%
Jul 2023
Worst month
-58.8%
Dec 2021
Positive months
53%
of all months
BridgeBio Pharma Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Aug 2026 | +1.4% | |
| Jul 2026 | +7.5% | |
| Jun 2026 | +12.4% | |
| May 2026 | -6.8% | |
| Apr 2026 | -4.2% | |
| Mar 2026 | +11.7% | |
| Feb 2026 | -14.0% | |
| Jan 2026 | +1.0% | |
| Dec 2025 | +6.2% | |
| Nov 2025 | +15.0% | |
| Oct 2025 | +20.6% | |
| Sep 2025 | +0.3% |
Monthly total return (since Sep 2021)
-100%-50%+0%+50%+100%
20222023202420252026
Methodology#
Monthly returns are total returns (dividends reinvested), computed from BBIO's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is BridgeBio Pharma Inc.'s average monthly return?
- BridgeBio Pharma Inc. (BBIO) has averaged about 3.11% per month, positive in roughly 53% of months. The best month was Jul 2023 (+103.5%) and the worst was Dec 2021 (-58.8%).